It Seems Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) Will Go Up. Just Reported Less Shorted Shares

September 17, 2017 - By Marie Mckinney

 It Seems Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) Will Go Up. Just Reported Less Shorted Shares

The stock of Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) registered a decrease of 6.15% in short interest. BLPH’s total short interest was 3.19M shares in September as published by FINRA. Its down 6.15% from 3.40M shares, reported previously. With 175,200 shares average volume, it will take short sellers 18 days to cover their BLPH’s short positions. The short interest to Bellerophon Therapeutics Incorporated’s float is 25.2%.

The stock increased 1.94% or $0.02 on September 15, reaching $1.05. About 508,102 shares traded or 46.61% up from the average. Bellerophon Therapeutics Inc (NASDAQ:BLPH) has risen 23.81% since September 17, 2016 and is uptrending. It has outperformed by 7.11% the S&P500.

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The company has market cap of $37.29 million. The Firm is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. It currently has negative earnings. The Firm is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension , using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication.

More notable recent Bellerophon Therapeutics Inc (NASDAQ:BLPH) news were published by: which released: “Bellerophon Therapeutics: 2017 Could Prove An Inflection Point In Valuation …” on April 10, 2017, also with their article: “Bellerophon Therapeutics Announces FDA Acceptance of Modifications to INOpulse …” published on January 04, 2017, published: “Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016” on September 20, 2016. More interesting news about Bellerophon Therapeutics Inc (NASDAQ:BLPH) were released by: and their article: “Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics …” published on October 26, 2016 as well as‘s news article titled: “Bellerophon Therapeutics, Inc. Announces $12 Million Public Offering” with publication date: November 23, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.